| scholarly article | Q13442814 |
| P50 | author | Johnny Ludvigsson | Q5965102 |
| Christiane S Hampe | Q44927527 | ||
| P2093 | author name string | R Casas | |
| M Chéramy | |||
| P2860 | cites work | Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies | Q28240917 |
| Stiff person syndrome | Q28248173 | ||
| Autoimmune type 1 diabetes: resolved and unresolved issues | Q28363451 | ||
| The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid | Q31406782 | ||
| Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10 | Q33412441 | ||
| An analysis of the cross-reactivity of autoantibodies to GAD65 and GAD67 in diabetes | Q33873549 | ||
| Characterization of CD4+ T cells specific for glutamic acid decarboxylase (GAD65) and proinsulin in a patient with stiff-person syndrome but without type 1 diabetes | Q33884262 | ||
| Respective implications of glutamate decarboxylase antibodies in stiff person syndrome and cerebellar ataxia | Q34162658 | ||
| Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus | Q34172103 | ||
| Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase | Q34566310 | ||
| GAD treatment and insulin secretion in recent-onset type 1 diabetes | Q34848774 | ||
| Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1. | Q37437161 | ||
| GAD autoantibody epitope pattern after GAD-alum treatment in children and adolescents with type 1 diabetes | Q37520366 | ||
| Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome | Q41196484 | ||
| Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets. | Q41511636 | ||
| Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes | Q44191950 | ||
| Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trial | Q45240370 | ||
| Progression to type 1 diabetes and autoantibody positivity in relation to HLA-risk genotypes in children participating in the ABIS study | Q45273607 | ||
| Latent autoimmune diabetes in an adult | Q46176878 | ||
| Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction | Q46314090 | ||
| Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients | Q46815045 | ||
| Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity | Q47311183 | ||
| Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome | Q47671744 | ||
| Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. | Q51689887 | ||
| Stiff-Person Syndrome | Q54165707 | ||
| Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus. | Q55034045 | ||
| Type 1 diabetes patients born to immigrants to Sweden increase their native diabetes risk and differ from Swedish patients in HLA types and islet autoantibodies | Q57449132 | ||
| GAD-alum treatment in patients with type 1 diabetes and the subsequent effect on GADA IgG subclass distribution, GAD65 enzyme activity and humoral response | Q57449133 | ||
| Screening for prediabetes in the general child population: maternal attitude to participation | Q57449474 | ||
| Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk | Q62587873 | ||
| Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition | Q70844237 | ||
| IgG subclass antibodies to glutamic acid decarboxylase and risk for progression to clinical insulin-dependent diabetes | Q77124590 | ||
| Recombinant Fabs of human monoclonal antibodies specific to the middle epitope of GAD65 inhibit type 1 diabetes-specific GAD65Abs | Q79207765 | ||
| Early epitope- and isotype-specific humoral immune responses to GAD65 in young children with genetic susceptibility to type 1 diabetes | Q80313062 | ||
| Humoral autoimmune responses to glutamic acid decarboxylase have similar target epitopes and subclass that show titer-dependent disease association | Q80388908 | ||
| Multiplicity of the antibody response to GAD65 in Type I diabetes | Q80892738 | ||
| Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes | Q81657563 | ||
| GAD65 IgG autoantibodies in stiff person syndrome: clonality, avidity and persistence | Q81661292 | ||
| Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes | Q83363049 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autoantibody | Q785022 |
| P304 | page(s) | 247-254 | |
| P577 | publication date | 2013-03-01 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Characteristics of in-vitro phenotypes of glutamic acid decarboxylase 65 autoantibodies in high-titre individuals | |
| P478 | volume | 171 |
| Q37278210 | Cellular and humoral immune responses in type 1 diabetic patients participating in a phase III GAD-alum intervention trial |
| Q35746485 | Elevated Serum GAD65 and GAD65-GADA Immune Complexes in Stiff Person Syndrome |
| Q47639572 | Multiplex family with GAD65-Abs neurologic syndromes |
| Q38289691 | Stiff-person syndrome: insights into a complex autoimmune disorder |
Search more.